TROYANOSYVIRUS
Retour aux CVEs

CVE-2026-21923

MEDIUM
6.5

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Details CVE

Score CVSS v3.16.5
SeveriteMEDIUM
Vecteur CVSSCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Vecteur d'attaqueNETWORK
ComplexiteLOW
Privileges requisNONE
Interaction utilisateurNONE
Publie1/20/2026
Derniere modification1/29/2026
Sourcenvd
Observations honeypot0

Produits affectes

oracle:life_sciences_central_designer

Correlations IOC

Aucune correlation enregistree

This product uses data from the NVD API but is not endorsed or certified by the NVD.